Biotech - Latest Articles

Former Seagen chief executive officer unveils brand new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually offered to Pfizer last year for an e...

.On the heels of a stage 3 gain that stopped working to excite entrepreneurs, Ironwood Pharmaceutica...

.Don't cease Monte Rosa Therapeutics now. The Boston-based biotech is enjoying after authorizing a h...

.Welcome to this week's Chutes &amp Ladders, our summary of significant management hirings, firings ...

.Celebrating his firm's upsized initial public offering (IPO), Septerna chief executive officer Jeff...

.AbbVie has gone back to the resource of its antipsychotic goliath Vraylar seeking yet another smash...

.GenSight Biologics is weeks off of lacking funds. Once again. The biotech just possesses sufficient...

.Monopar Rehabs is actually recovering a drug coming from the dump of AstraZeneca's uncommon disease...

.With brand new records out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of analysts...

.After forming a gene therapy collaboration with Dyno Therapeutics in 2020, Roche is actually back f...

.Lundbeck is actually lowering guide market value of its own $250 million Abide Therapies acquistion...

.The combination of real-world information (RWD) into process expediency and web site selection has ...

.At this year's Tough Biotech Top in Boston ma, we caught up with forerunners in the biotech industr...

.Merck &amp Co. is actually putting down $30 million beforehand to acquire Yale spinout Modifi Biosc...

.Alpha-9 Oncology has actually increased a $175 thousand series C round to money its own clinical-st...

.Eye medication producer Ocuphire Pharma is actually acquiring genetics treatment designer Opus Gene...

.Roche's persistent coughing system has faltered to a halt. The drugmaker, which axed the plan after...

.Gilead Sciences and also Merck &amp Co. have actually led their once-weekly HIV mixture treatment p...

.Lykos Therapies may possess shed three-quarters of its own team in the wake of the FDA's turndown o...

.Septerna may be actually as yet to reveal "any sort of relevant clinical data," yet the biotech acc...